Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05047419 · ClinicalTrials.gov registry record
Asthma in Pregnancy
A clinical trial, sponsored by Linnea Polgreen.
- Completed
- Registry status
- 83
- Enrollment target
NCT05047419: Completed study, sponsored by Linnea Polgreen.
NCT05047419 is a clinical trial that has completed, run by Linnea Polgreen. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05047419 has completed, sponsored by Linnea Polgreen.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
The long-term goal is to improve the care of patients with asthma. The overarching objective of this pilot grant is to test the feasibility, acceptability and potential clinical utility of deploying a mobile-health intervention to improve asthma surveillance.
Primary Outcome
Comparison of number of peak flow measurements received between pregnant and not pregnant groups.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2023-02-28 |
What the finished NCT05047419 record still lists
NCT05047419 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05047419 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05047419 about?
NCT05047419 is a clinical study titled "Asthma in Pregnancy". The long-term goal is to improve the care of patients with asthma. The overarching objective of this pilot grant is to test the feasibility, acceptability and potential clinical utility of deploying a mobile-health intervention to improve asthma surveillance.
What is the current status of trial NCT05047419?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2021-08-27. Estimated completion is 2023-02-28.
Who is sponsoring clinical trial NCT05047419?
This trial is sponsored by Linnea Polgreen, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI